COMPARING THE QUALITY-ADJUSTED LIFE-YEAR OUTPUT OF 2 TREATMENT ARMS IN A RANDOMIZED TRIAL

被引:0
|
作者
GANIATS, TG [1 ]
MILLER, CJ [1 ]
KAPLAN, RM [1 ]
机构
[1] UNIV CALIF SAN DIEGO, HLTH OUTCOMES ASSESSMENT PROGRAM, LA JOLLA, CA 92093 USA
关键词
QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS; DATA INTERPRETATION; STATISTICAL; QUALITY-ADJUSTED LIFE YEARS;
D O I
暂无
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
The quality-adjusted life year (QALY) is an outcome measure with two dimensions: wellness and time. It is difficult to compare the QALY output of two groups when subjects are observed for varying time periods, because both elements of the two-dimensional outcome measure vary in all subjects. This paper evaluates the strengths and weaknesses of five approaches for making these comparisons. These approaches are: a subject-based approach, the elimination of time, calculation of the mean of available data, use of quality-adjusted survival analysis, and calculation of a maximum likelihood estimation. It is concluded that the maximum likelihood estimation offers significant advantages over the other methods.
引用
收藏
页码:AS245 / AS254
页数:10
相关论文
共 50 条
  • [21] The Worth of a Quality-Adjusted Life-Year in Patients with Diabetes: An Investigation Study using a Willingness-to-Pay Method
    Moradi, Najme
    Rashidian, Arash
    Nosratnejad, Shirin
    Olyaeemanesh, Alireza
    Zanganeh, Marzieh
    Zarei, Leila
    [J]. PHARMACOECONOMICS-OPEN, 2019, 3 (03) : 311 - 319
  • [22] EXPLORING THE FEASIBILITY OF THE INSTRUMENT USED IN DETERMINATION OF WILLINGNESS-TO-PAY PER QUALITY-ADJUSTED LIFE-YEAR IN MALAYSIA
    Lim, Y. W.
    Shafie, A. A.
    Hassali, M. A. A.
    Chua, G. N.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A596 - A597
  • [23] Quality-Adjusted Life Years, Quality-Adjusted Life-Year-Like Measures, or Neither? The Debate Continues
    Devlin, Nancy J.
    Drummond, Michael F.
    Mullins, C. Daniel
    [J]. VALUE IN HEALTH, 2024, 27 (06) : 689 - 691
  • [24] Estimated Quality-Adjusted Life-Year Associated with the Degree of Activities of Daily Living in Patients with Alzheimer's Disease
    Kasai, Mari
    Meguro, Kenichi
    [J]. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS EXTRA, 2013, 3 (01): : 482 - 488
  • [25] Quality-Adjusted Life-Year Losses Averted With Every COVID-19 Infection Prevented in the United States
    Basu, Anirban
    Gandhay, Varun J.
    [J]. VALUE IN HEALTH, 2021, 24 (05) : 632 - 640
  • [26] The Worth of a Quality-Adjusted Life-Year in Patients with Diabetes: An Investigation Study using a Willingness-to-Pay Method
    Najme Moradi
    Arash Rashidian
    Shirin Nosratnejad
    Alireza Olyaeemanesh
    Marzieh Zanganeh
    Leila Zarei
    [J]. PharmacoEconomics - Open, 2019, 3 : 311 - 319
  • [27] Willingness-to-Pay for One Quality-Adjusted Life-Year: A Population-Based Study from Iran
    Kamran Bagheri Lankarani
    Sulmaz Ghahramani
    Najmeh Moradi
    Hadi Raeisi Shahraki
    Farhad Lotfi
    Behnam Honarvar
    [J]. Applied Health Economics and Health Policy, 2018, 16 : 837 - 846
  • [28] Willingness-to-Pay for One Quality-Adjusted Life-Year: A Population-Based Study from Iran
    Lankarani, Kamran Bagheri
    Ghahramani, Sulmaz
    Moradi, Najmeh
    Shahraki, Hadi Raeisi
    Lotfi, Farhad
    Honarvar, Behnam
    [J]. APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2018, 16 (06) : 837 - 846
  • [29] Empirical Monetary Valuation of a Quality-Adjusted Life-Year in the Kingdom of Saudi Arabia: A Willingness-to-Pay Analysis
    Bazarbashi, Shouki
    De Vol, Edward B.
    Maraiki, Fatma
    Al-Jedai, Ahmed
    Ali, Afshan A.
    Alhammad, Ali M.
    Aljuffali, Ibrahim A.
    Iskedjian, Michael
    [J]. PHARMACOECONOMICS-OPEN, 2020, 4 (04) : 625 - 633
  • [30] Is the UK NICE "Reference Case" Influencing the Practice of Pediatric Quality-Adjusted Life-Year Measurement within Economic Evaluations?
    Adlard, Nick
    Kinghorn, Philip
    Frew, Emma
    [J]. VALUE IN HEALTH, 2014, 17 (04) : 454 - 461